GOLDENWELL BIOTECH, INC. (GWLL) › Cash & EquivalentsGOLDENWELL BIOTECH, INC. (GWLL) — Cash & EquivalentsAnnual figures by period end, from SEC filings.2018-12-31: $02019-12-31: $246.6K2020-12-31: $248.6K2021-12-31: $213.6K2022-12-31: $46.0K$46.0K2018-12-31Cash & Equivalents (USD)2022-12-31Period endedCash & EquivalentsChange YoYSource filing2022-12-31$46.0K-78.5%2023-04-13Balance as of period end2021-12-31$213.6K-14.1%2023-04-13Balance as of period end2020-12-31$248.6K+0.8%2023-02-06Balance as of period end2019-12-31$246.6K—2022-04-01Balance as of period end2018-12-31$0—2021-07-23Balance as of period endOther metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)